People

Maurizio Fava
Maurizio Fava serves as Scientific Advisory Board Member at Newleos Therapeutics, a clinical-stage neuroscience company. Maurizio Fava MD is a published external PureTech collaborator and executive vice chair of psychiatry and director of the clinical trials network and institute at Massachusetts General Hospital. His existing Newleos scientific advisory identity and portrait are preserved.
Roles
Damona Pharmaceuticals
CurrentScientific Advisory Board Member
Newleos Therapeutics
CurrentScientific Advisory Board Member
Iaso Ventures
CurrentAdvisor, Clinical R&D
Sensorium Therapeutics
CurrentScientific and Clinical Advisor
PureTech Health
CurrentScientific Collaborator (external; published network)
Click Therapeutics
CurrentScientific Advisor
Dolby Family Ventures
CurrentScientific Advisory Board Member